RALEIGH, N.C.—Drugmaker GlaxoSmithKline shut down a plant
Tuesday that produces inhaled medications after discovering the
bacteria that causes Legionnaires' disease, a potentially fatal
form of pneumonia.
The manufacturing plant in Zebulon, about 25 miles east of
Raleigh, was closed after routine testing found the bacteria in a
self-standing cooling tower. About 400 of the 850 employees who
work in Zebulon were told to stay away until the towers are
cleaned, officials for the London-based company said.
The company said in a statement that the cooling tower "does not
come into contact with product manufactured at the facility."
Glaxo didn't respond to questions about whether there was any
risk of indoor exposure to employees or medicines from water
droplets that could carry the bacteria.
"We are trying to gather information on what the situation is,"
spokeswoman Jenni Brewer Ligday said. "It was found during routine
testing, so we're trying to get a better handle of how often those
testings are conducted, also more details on whether product has
been impacted and, if they have, what is our procedure in place to
handle that."
The plant produces inhaled drugs like Advair, a drug for asthma,
and contracts with other pharmaceutical companies to produce their
drugs.
The Food and Drug Administration was checking into reports of
the bacteria's discovery, and a spokesman had no immediate
comment.
State and county health officials said they weren't aware of any
Legionnaire's disease cases associated with the Glaxo facility,
adding that most people who are exposed to the bacteria don't
become ill.
The same bacteria found in cooling tanks in the Bronx borough of
New York City has caused 12 deaths this summer. The Centers for
Disease Control and Prevention says about 8,000 to 18,000 Americans
are hospitalized with the illness annually.
People can contract Legionnaires' disease when they inhale water
vapor or mist containing the bacteria, the CDC said. It doesn't
spread from person to person, the agency said.
Copyright 2015 The Associated Press